Display options
Cite
Calvo F, Sole C, Herranz R, et al. Intraoperative radiotherapy with electrons: fundamentals, results, and innovation. Ecancermedicalscience. 2013;7:339doi: 10.3332/ecancer.2013.339.
Calvo, F., Sole, C., Herranz, R., Lopez-Bote, M., Pascau, J., Santos, A., Muñoz-Calero, A., Ferrer, C., & Garcia-Sabrido, J. (2013). Intraoperative radiotherapy with electrons: fundamentals, results, and innovation. Ecancermedicalscience, 7339. https://doi.org/10.3332/ecancer.2013.339
Calvo, Fa, et al. "Intraoperative radiotherapy with electrons: fundamentals, results, and innovation." Ecancermedicalscience vol. 7 (2013): 339. doi: https://doi.org/10.3332/ecancer.2013.339
Calvo F, Sole C, Herranz R, Lopez-Bote M, Pascau J, Santos A, Muñoz-Calero A, Ferrer C, Garcia-Sabrido J. Intraoperative radiotherapy with electrons: fundamentals, results, and innovation. Ecancermedicalscience. 2013 Aug 15;7:339. doi: 10.3332/ecancer.2013.339. eCollection 2013. PMID: 24009641; PMCID: PMC3757959.
Copy Download .nbib Format: NLM
Share it on

Ecancermedicalscience. 2013 Aug 15;7:339. doi: 10.3332/ecancer.2013.339. eCollection 2013.

Intraoperative radiotherapy with electrons: fundamentals, results, and innovation.

Ecancermedicalscience

Fa Calvo, Cv Sole, R Herranz, M Lopez-Bote, J Pascau, A Santos, A Muñoz-Calero, C Ferrer, Jl Garcia-Sabrido

Affiliations

  1. Department of Oncology, Gregorio Marañón General University Hospital, Madrid 28007, Spain ; School of Medicine, Complutense University, Madrid, Spain ; Institute of Research Investigation, Gregorio Marañón General University Hospital, Madrid 28007, Spain.

PMID: 24009641 PMCID: PMC3757959 DOI: 10.3332/ecancer.2013.339

Abstract

RATIONALE AND OBJECTIVES: To analyse the programme activity and clinical innovation and/or technology developed over a period of 17 years with regard to the introduction and the use of intraoperative radiotherapy (IORT) as a therapeutic component in a medical-surgical multidisciplinary cancer hospital.

MATERIAL AND METHODS: To standardise and record this procedure, the Radiation Oncology service has an institutional programme and protocols that must be completed by the different specialists involved. For 17 years, IORT procedures were recorded on a specific database that includes 23 variables with information recorded on institutional protocols. As part of the development and innovation activity, two technological tools were implemented (RADIANCE and MEDTING) in line with the standardisation of this modality in clinical practice.

RESULTS: During the 17 years studied, 1,004 patients were treated through 1,036 IORT procedures. The state of the disease at the time of IORT was 77% primary and 23% recurrent. The origin and distribution of cancers were 62% gastrointestinal, 18% sarcomas, 5% pancreatic, 2% paediatric, 3% breast, 7% less common locations, and 2% others. The research and development projects have generated a patent on virtual planning (RADIANCE) and proof of concept to explore as a professional social network (MEDTING). During 2012, there were 69 IORT procedures. There was defined treatment volume (target or target region) in all of them, and 43 were conducted by the virtual planning RADIANCE system. Eighteen have been registered on the platform MEDTING as clinical cases.

CONCLUSION: The IORT programme, developed in a university hospital with an academic tradition, and interdisciplinary surgical oncology, is a feasible care initiative, able to generate the necessary intense clinical activity for tending to the cancer patient. Moreover, it is a competitive source for research, development, and scientific innovation.

Keywords: MEDTING; RADIANCE; disease-free survival; global survival; innovative activity; intraoperative radiotherapy; multidisciplinary; standardisation

References

  1. Eur J Surg Oncol. 2012 Oct;38(10):955-61 - PubMed
  2. Rep Pract Oncol Radiother. 2013 Aug 13;19(4):246-52 - PubMed
  3. Crit Rev Oncol Hematol. 2006 Aug;59(2):116-27 - PubMed
  4. Radiother Oncol. 2002 Feb;62(2):201-6 - PubMed
  5. Radiother Oncol. 2009 Apr;91(1):54-9 - PubMed
  6. Ann Surg Oncol. 2013 Jun;20(6):1962-9 - PubMed
  7. Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):892-900 - PubMed
  8. Clin Transl Oncol. 2013 Sep;15(9):683-90 - PubMed
  9. Rep Pract Oncol Radiother. 2013 Sep 28;19(4):253-8 - PubMed
  10. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e287-95 - PubMed
  11. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1122-8 - PubMed
  12. Clin Transl Oncol. 2013 Jun;15(6):443-9 - PubMed

Publication Types